> Take me to the Patient Section  > Take me to the Public Section

HEALTHCARE PROFESSIONALS

About the ‘ey’ range

There are several products in the ‘ey’ range, which have been designed with both ophthalmologists and patients in mind.

Eysanoboxx2
More Info
Eydeltoboxx2
More Info
Eylamdoboxx2
More Info
Eykappoboxx2
More Info

The ‘ey’ eye drops offer:

  • Preservative free solution1, to avoid irritation of the ocular surface caused by commonly used preservatives2
  • Precision multi-dose device3
  • Patient centric design3,4
  • Established molecule1

For more information about the multi-dose bottle and how best to administer the eye drops, please refer to the video link below.

Please be aware that there might be a few seconds delay between squeezing the bottle and the eye drops coming out.

Precision, Multidose
Device

The ey range dropper offers a multidose closing tip system, which avoids the need for preservatives in the solution and prevents bacterial contamination of the solution over the in-use shelf-life.

Silver is incorporated within the nozzle top and cap to prevent bacterial contamination in any residual solution which might remain on the tip5

Patient Centric Design

Calibrated drops. One drop at a time4

High visibility colours, coded by molecule. Allows patients to differentiate between products

Easy to squeeze bottle4

Blue tip assists the patient to aim drops into the eye4

References
1) Ey product Summary of Product Characteristics  2) Pisella et al, Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication, Br J Ophthalmol. 2002 Apr;86(4):418-23.  3) Novelia® PureFlow Technology. http://www.nemera.net/wp-content/uploads/2014/06/WP-Novelia-alternativetofilters-June2015.pdf (accessed November 2017)   4) Novelia® PureFlow http://www.nemera.net/wp-content/uploads/2014/06/Novelia-WP_Sept2014.pdf (accessed November 2017)  5) Data on file, 1010347217 V2.0 May 2017

For further information please call: 01730 231148,
email: info@aspirepharma.co.uk or visit www.aspirepharma.co.uk

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148
For more information about the Ey Range, please see the abbreviated prescribing information.
Revision reference – Ey Range_1_18/12/2017